Sensor-Based Inhaler Analytics for Asthma Management

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for monitoring and managing respiratory diseases such as asthma, COPD, and cystic fibrosis are inadequate, relying on subjective patient reports and lacking real-time data, which leads to inefficiencies in symptom control and increased healthcare costs.

Innovation Solution

A respiratory disease analytics system that uses sensors attached to medicament devices to track medication usage and provide real-time data analysis, offering risk assessments and adherence reminders to both patients and healthcare providers through a unified platform.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If periodic written questionnaires are used to monitor patients, then patient assessment can be conducted, but measurement precision deteriorates due to recall biases and subjective reporting

Engineering Contradiction:
Improvepatient assessment accuracyVSAvoiddata reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent replaces manual written questionnaires with an automated sensor-based system. Sensors attached to inhalers automatically detect and report medication usage events, eliminating the need for patients to manually recall and report their usage. This substitution of mechanical/manual systems with automated electronic sensing resolves the measurement precision issue by providing objective, accurate data without recall biases.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system enables self-service monitoring where the inhaler sensor automatically tracks and reports medication usage without requiring patient intervention. The sensor continuously monitors inhaler activation and automatically transmits data to the healthcare provider's system, eliminating the need for patients to actively report their usage patterns and thereby improving data reliability.

Inventive Principle:
Principle #25Self-service

2Productivity

If real-time monitoring systems are implemented, then disease management improves, but device complexity increases

Engineering Contradiction:
Improvedisease management efficiencyVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the monitoring system into distinct functional components: a simple sensor attached to the inhaler for data collection, a communication module for data transmission, and a separate healthcare provider interface for analysis and intervention. This segmentation allows each component to remain relatively simple while the overall system achieves real-time monitoring capability, thus improving disease management efficiency without excessive complexity in any single component.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a communication interface as an intermediary between the inhaler sensor and the healthcare provider system. This intermediary handles the data transmission and initial processing, allowing the main system to focus on monitoring and intervention without becoming overly complex. The intermediary simplifies the architecture by separating data collection, transmission, and analysis functions.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If automated sensor tracking is used, then user bias is reduced, but manufacturing precision requirements increase

Engineering Contradiction:
Improvedata objectivityVSAvoidsensor accuracy
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent extracts the critical measurement function from the complex inhaler device itself and places it in a separate, dedicated sensor component. This sensor specifically monitors inhaler activation events and transmits only this objective data, separating the measurement function from the medication delivery function. By taking out the monitoring function, the system achieves reliable objective data without requiring the inhaler manufacturing to meet extremely high precision requirements.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS11798667B2Dynamic graphical user interface for interaction with patient respiratory disease data
Publication Date: 2023.10.24 RESMED INC
  • US11798667B2 patent drawing
  • US11798667B2 patent drawing
  • US11798667B2 patent drawing

AI summary

This description relates to insight into the asthma management habits of a patient or a plurality of patients. The provided information includes records of rescue medication usage events, records of controller medication events, and overall evaluations of a patients disease management. Users of the application may include both patients who may use the information to monitor their own habits or providers who may use the information to monitor patients or improve a patient's existing medication regimen.